Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Interest Expenses (2011 - 2026)

Emergent BioSolutions (EBS) posted Interest Expenses of $10.0 million for Q2 2026, down 9.09% on a QoQ basis from $11.0 million in Q1 2026, and down 31.97% year-over-year from $14.7 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Interest Expenses (2011 - 2026) Analysis & Trends

Emergent BioSolutions has reported Interest Expenses for 16 years, with the latest figure at $10.0 million in Q2 2026.

  • On a quarterly basis, Interest Expenses fell 31.97% year-over-year to $10.0 million in Q2 2026; TTM through Jun 2026 was $50.9 million, a 3.05% decrease from a year earlier, with the FY2025 full-year figure at $59.3 million, down 16.48% from the prior year.
  • Interest Expenses was $10.0 million for Q2 2026 at Emergent BioSolutions, down from $11.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $28.6 million in Q2 2023, with the low at $7.8 million in Q2 2022.
  • Average Interest Expenses over 5 years is $15.4 million, with a median of $14.7 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Interest Expenses soared 266.67% in 2023, then slumped 57.87% in 2024.
  • Over 5 years, Interest Expenses stood at $12.8 million in 2022, then surged by 69.53% to $21.7 million in 2023, then sank by 31.8% to $14.8 million in 2024, then slipped by 0.68% to $14.7 million in 2025, then tumbled by 31.97% to $10.0 million in 2026.
  • The last three Interest Expenses figures came in at $10.0 million (Q2 2026), $11.0 million (Q1 2026), and $14.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 281.00 Mn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn -
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -333.60 Mn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 39.74 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - 23.78 Mn
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.00 Mn
Mar 31, 2026 11.00 Mn
Dec 31, 2025 14.70 Mn
Sep 30, 2025 15.20 Mn
Jun 30, 2025 14.70 Mn
Mar 31, 2025 14.70 Mn
Dec 31, 2024 14.80 Mn
Sep 30, 2024 8.30 Mn
Jun 30, 2024 23.60 Mn
Mar 31, 2024 24.30 Mn
Dec 31, 2023 21.70 Mn
Sep 30, 2023 19.70 Mn
Jun 30, 2023 28.60 Mn
Mar 31, 2023 17.90 Mn
Dec 31, 2022 12.80 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 7.80 Mn
Mar 31, 2022 8.20 Mn
Dec 31, 2021 9.00 Mn
Sep 30, 2021 8.40 Mn
API Access

Emergent BioSolutions Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY